ONCSQ — OncoSec Medical Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$1.39m
Annual balance sheet for OncoSec Medical, fiscal year end - July 31st, USD millions except per share, conversion factor applied.
2018 July 31st | 2019 July 31st | 2020 July 31st | 2021 July 31st | 2022 July 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 27 | 25.1 | 20.4 | 46 | 12.3 |
Prepaid Expenses | |||||
Total Current Assets | 28.6 | 28.5 | 22.8 | 49.2 | 15.2 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1.27 | 1.03 | 6.76 | 6.37 | 5.64 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 30.2 | 29.9 | 29.9 | 56.3 | 21.9 |
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 5.85 | 4.98 | 9.68 | 7.96 | 6.63 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 7.32 | 5.61 | 16 | 18.2 | 15.8 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 22.9 | 24.3 | 13.9 | 38.1 | 6.12 |
Total Liabilities & Shareholders' Equity | 30.2 | 29.9 | 29.9 | 56.3 | 21.9 |
Total Common Shares Outstanding |